" /> " /> Redfern Hep C article published. Treatment feasible and effective.<script type="text/javascript" src="http://www.blogger.com/static/v1/common/js/1499043574-csitaillib.js"></script> <script>if (typeof(window.attachCsiOnload) != 'undefined' && window.attachCsiOnload != null) { window.attachCsiOnload('ext_blogspot'); }</script>
Skip to main menu | Skip to content

  Redfern Hep C article published. Treatment feasible and effective.

Posted: May 05, 2007 20:32
Dear Colleagues,

Our article on hepatitis C is published this week.

We describe a population of injecting drug users taking methadone and buprenorphine treatment (n=237) with a HCV seroprevalence of 75%. A third of seropositive people had risk factors for disease progression and were targeted for referral for possible treatment. There were 27 who attended a liver clinic during the 3 year study period, of whom 14 started treatment with pegylated interferon-alpha and ribavirin, most with very gratifying results. [At latest count 24 patients have been treated]

Hallinan R, Byrne A, Agho K, Dore GJ. Referral for chronic hepatitis C treatment from a drug dependency treatment setting, D&A Dependence 2007 88;1:49-53

abstract: http://dx.doi.org/10.1016/j.drugalcdep.2006.09.018
 

Disclaimer

On this web site, Dr Byrne and colleagues have written summaries of many research articles, conferences and other events. These have been written largely to draw attention to peer-reviewed studies which may be relevant to clinical practice and public policy. While all care has been taken to be fair and accurate, readers are strongly advised to read the original publications before acting upon the information for clinical decisions.

Due to this brief form of communication, no responsibility can be taken for errors, mistakes or omissions.

Reputable sources of health information for the general public:

© andrew byrne     +61 2 9319 5524
Valid XHTML 1.0 Transitional Mostly CSS validated but hacked for IE!